| abstract |
The present disclosure relates to indazole derivatives, preparation process and medical use thereof. In particular, the present disclosure relates to an indazole derivative represented by the general formula (I), a preparation process thereof and a pharmaceutical composition containing the same, as well as use thereof as an estrogen receptor modulator for preventing and/or treating estrogen receptor mediated or dependent diseases or disorders, said diseases being particularly preferably breast cancer. The substituents of general formula (I) are the same as defined in the description. |